December 31, 2024 - 14:37

In a recent discussion on market cycles, Robert Sluymer, a technical strategist at RBC Wealth Management, provided insights into the current state of the financial markets. Sluymer emphasized that market cycles are characterized by recurring patterns of rising and falling asset prices, typically moving through phases of growth, peak, decline, and recovery. He noted that these generational cycles usually span 16 to 18 years, and we are currently in a bull market that began in 2010, which he believes will extend into the 2030s.
According to Sluymer, the market tends to experience "a series of higher highs and higher lows" during these cycles, indicating a sustained uptrend that generally lasts about four years. He pointed out that central bank liquidity and the economy's response to that liquidity, along with corporate earnings, are significant factors influencing these market cycles. For investors, Sluymer advised that while patterns may not be identical each time, understanding these cycles is crucial for effective investment strategies.
March 17, 2026 - 05:46
Virginia joins multi-state lawsuit against OneMain FinancialVirginia has officially joined a coalition of a dozen states in filing a lawsuit against OneMain Financial, a major consumer loan company. The legal action, announced by Attorney General Jay Jones,...
March 16, 2026 - 02:28
Barclays Lifts PT on EOG Resources (EOG) to $140 From $133In a recent move underscoring confidence in the energy sector, investment bank Barclays has increased its price target for EOG Resources, Inc. The firm lifted its target to $140 per share, up from...
March 15, 2026 - 05:53
Peak War Panic Predicted to Grip Markets Within WeeksA leading market strategist warns that global financial markets are likely to experience a peak period of war-induced panic within the next one to three weeks. This forecast comes as both the...
March 14, 2026 - 22:13
A Look At Afya (NasdaqGS:AFYA) Valuation After Recent Mixed Share Price PerformanceThe valuation of Brazilian medical education leader Afya is under scrutiny following a period of mixed performance for its shares. While the stock experienced a modest single-day gain of...